4.7 Article

Practical guideline on obesity care in patients with gastrointestinal and liver diseases- Joint ESPEN/UEG guideline

期刊

CLINICAL NUTRITION
卷 42, 期 6, 页码 987-1024

出版社

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.clnu.2023.03.021

关键词

Obesity; Sarcopenic obesity; Inflammatory bowel disease; Irritable bowel syndrome celiac disease; Gastroesophagealreflux disease; Pancreatitis

向作者/读者索取更多资源

This practical guideline focuses on the diagnosis and treatment of obesity in patients with chronic gastrointestinal diseases, with a particular emphasis on metabolic associated liver disease. The guideline provides evidence-based advice in a condensed format, with 100 recommendations covering a multidisciplinary approach to care.
Background: Patients with chronic gastrointestinal disease such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), pancreatitis, and chronic liver disease (CLD) often suffer from obesity because of coincidence (IBD, IBS, celiac disease) or related pathophysiology (GERD, pancreatitis and CLD). It is unclear if such patients need a particular diagnostic and treatment that differs from the needs of lean gastrointestinal patients. The present guideline addresses this question according to current knowledge and evidence. Objective: The present practical guideline is intended for clinicians and practitioners in general medicine, gastroenterology, surgery and other obesity management, including dietitians and focuses on obesity care in patients with chronic gastrointestinal diseases. Methods: The present practical guideline is the shortened version of a previously published scientific guideline developed according to the standard operating procedure for ESPEN guidelines. The content has been re-structured and transformed into flow-charts that allow a quick navigation through the text.Results: In 100 recommendations (3x A, 33x B, 24 x 0, 40x GPP, all with a consensus grade of 90% or more) care of gastrointestinal patients with obesity -including sarcopenic obesity -is addressed in a multidisciplinary way. A particular emphasis is on CLD, especially metabolic associated liver disease, since such diseases are closely related to obesity, whereas liver cirrhosis is rather associated with sar-copenic obesity. A special chapter is dedicated to obesity care in patients undergoing bariatric surgery. The guideline focuses on adults, not on children, for whom data are scarce. Whether some of the rec-ommendations apply to children must be left to the judgment of the experienced pediatrician.Conclusion: The present practical guideline offers in a condensed way evidence-based advice how to care for patients with chronic gastrointestinal diseases and concomitant obesity, an increasingly frequent constellation in clinical practice.(c) 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据